In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis (Q34106465)

31 July 2017

In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

31 July 2017

0 references

author name string

Enrique J Alvirez-Freites

series ordinal

1

1 reference

31 July 2017

Janna L Carter

series ordinal

2

1 reference

31 July 2017

Michael H Cynamon

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

31 July 2017

46

1 reference

31 July 2017

4

1 reference

31 July 2017

1022-1025

1 reference

Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

The role of fluoroquinolones in tuberculosis today

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Activity of moxifloxacin against mycobacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

[Clinical evaluation of new quinolones as antituberculosis drugs]

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Activity of levofloxacin in a murine model of tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Inflammatory response following intranasal infection with Mycobacterium avium complex: role of T-cell subsets and gamma interferon

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulare

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127120

Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11897584

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro activity of ofloxacin against Mycobacterium tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11897584

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.46.4.1022-1025.2002

1 reference

31 July 2017

1 reference

31 July 2017

1 reference